RGLS – regulus therapeutics inc. (US:NASDAQ)
Stock Stats
News
Global Antisense and RNAi Therapeutics Report 2024: A USD 34.7 Billion Predicted Market by 2034, with CAGR of 18% During 2024-2034 [Yahoo! Finance]
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Regulus: It Is Finding Its Stride Despite Initial Setback In Targeting ADPKD [Seeking Alpha]
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Form EFFECT Regulus Therapeutics
Form ARS Regulus Therapeutics For: Dec 31
Form DEF 14A Regulus Therapeutics For: May 16
Form SC 13G/A Regulus Therapeutics Filed by: FMR LLC
Form S-3 Regulus Therapeutics
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.